Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor Diseases
Open Access
- 28 February 2025
- journal article
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 45 (3) , 279-290
Abstract
Sung-Soo Park, M.D., Ph.D., Na Yung Kim, M.S., Ji-Young Lim, Ph.D., Jung Yeon Lee, M.D., Sujin Yun, B.S., Yeun-Jun Chung, M.D., Ph.D., Seung-Hyun Jung, Ph.D., and Chang-Ki Min, M.D., Ph.D.. Ann Lab Med 2025;45:279-90. https://doi.org/10.3343/alm.2024.0424Keywords
Funding Information
- National Research Foundation of Korea (2019R1C1C1004909, 2021R1G1A1093870, RS-2024-00450891, 2021R1A2C2093566, 2019R1A5A2027588)
This publication has 38 references indexed in Scilit:
- Circulating Tumor DNA as a Liquid Biopsy for CancerClinical Chemistry, 2015
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted TherapyCancer Cell, 2014
- Extramedullary multiple myelomaLeukemia & Lymphoma, 2012
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tidesBlood, 2012
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerNature Genetics, 2012
- Initial genome sequencing and analysis of multiple myelomaNature, 2011
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyBlood, 2009
- An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myelomaBlood, 2008
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005